ArticleProceedings of the National Academy of Sciences of the United States of America2019

p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.